
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Certara, a provider of drug development, regulatory science, real-world evidence, and market access, announced the launch of version 2.3 of its Trial Simulator software in order to help drug developers improve clinical trial design by testing new ideas and evaluating trials for every phase of clinical drug development.
Read the full release






